Insider Purchase by Director
On July 30, 2026, Thomas Kosasa, a director and 10% owner of OneMedNet Corp. (NASDAQ: ONMD), acquired 1,449,275 shares of the company’s common stock through a subscription agreement, investing a total of $1,000,000. The shares were bought at $0.69 each, a price derived from the volume‑weighted average price (VWAP) of OneMedNet’s stock over the ten trading days preceding the purchase. Following the transaction, Kosasa’s directly beneficial ownership increased to 18,538,150 shares, equating to a 10% stake in the issuer. At the time of reporting, OneMedNet’s shares were trading at $0.62, reflecting a 13% decline over the prior week, and the company’s market capitalization stood at $35.5 million. The purchase price matches InvestingPro’s fair‑value estimate, indicating the insider considered the stock fairly valued despite the company’s rapid cash burn and lack of profitability over the last twelve months.
New Bookings Announcement
In a separate press release, OneMedNet disclosed that it has secured more than $3 million in new bookings for the year 2026. This amount exceeds the total bookings the company recorded for the entirety of 2025. The firm expects to recognize the majority of these bookings as revenue by the end of the third quarter of 2026. The announcement highlighted the company’s focus on delivering real‑world data solutions to life‑sciences organizations, though no specific clients or projects were identified.
Additional Context
The article was generated with AI assistance and reviewed by an editor, with reference to InvestingPro’s analysis that provides five ProTips for ONMD investors. No further details on the composition of the new bookings or the company’s cash‑flow outlook were disclosed.